Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Logothetis

Showing results (621-630 of 1,104) with videos related to

Pageof 111
Sort By:
Journal of Clinical Pharmacology|August 1, 1988
The correlation of vinblastine pharmacokinetics to toxicity in testicular cancer patientsC D Chong, C J Logothetis, N Savaraj, et al.
Cell Reports|January 4, 2016
Epilepsy-Related Slack Channel Mutants Lead to Channel Over-Activity by Two Different MechanismsQiong-Yao Tang, Fei-Fei Zhang, Jie Xu, et al.
Nature Neuroscience|September 7, 2010
The effects of electrical microstimulation on cortical signal propagationNikos K Logothetis, Mark Augath, Yusuke Murayama, et al.
Scientific Reports|November 17, 2021
Activation of specific bitter taste receptors by olive oil phenolics and secoiridoidsMeng Cui, Bohan Chen, Keman Xu, et al.
Cancer|May 15, 1987
Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 casesB Têtu, J Y Ro, A G Ayala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary resultsC A Pettaway, L L Pisters, P Troncoso, et al.
Psychopharmacology|January 1, 1989
Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the ratS A Parashos, P Barone, C A Marin, et al.
Cancer|June 5, 2003
A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastasesLance C Pagliaro, Ebrahim S Delpassand, Dallas Williams, et al.
Urologic Oncology|May 10, 2001
Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancerR Millikan, L Baez, T Banerjee, et al.
Journal of the National Medical Association|December 30, 2004
Prognostic factors for survival among Caucasian, African-American and Hispanic men with androgen-independent prostate cancerReena B Wyatt, Ricardo F Sánchez-Ortiz, Christopher G Wood, et al.
Pageof 111

Showing results (621-630 of 1,104) with videos related to

Sort By:
Pageof 111
Journal of Clinical Pharmacology|August 1, 1988
The correlation of vinblastine pharmacokinetics to toxicity in testicular cancer patientsC D Chong, C J Logothetis, N Savaraj, et al.
Cell Reports|January 4, 2016
Epilepsy-Related Slack Channel Mutants Lead to Channel Over-Activity by Two Different MechanismsQiong-Yao Tang, Fei-Fei Zhang, Jie Xu, et al.
Nature Neuroscience|September 7, 2010
The effects of electrical microstimulation on cortical signal propagationNikos K Logothetis, Mark Augath, Yusuke Murayama, et al.
Scientific Reports|November 17, 2021
Activation of specific bitter taste receptors by olive oil phenolics and secoiridoidsMeng Cui, Bohan Chen, Keman Xu, et al.
Cancer|May 15, 1987
Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 casesB Têtu, J Y Ro, A G Ayala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary resultsC A Pettaway, L L Pisters, P Troncoso, et al.
Psychopharmacology|January 1, 1989
Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the ratS A Parashos, P Barone, C A Marin, et al.
Cancer|June 5, 2003
A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastasesLance C Pagliaro, Ebrahim S Delpassand, Dallas Williams, et al.
Urologic Oncology|May 10, 2001
Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancerR Millikan, L Baez, T Banerjee, et al.
Journal of the National Medical Association|December 30, 2004
Prognostic factors for survival among Caucasian, African-American and Hispanic men with androgen-independent prostate cancerReena B Wyatt, Ricardo F Sánchez-Ortiz, Christopher G Wood, et al.
Pageof 111